Tranilast is an amidobenzoic acid that is anthranilic acid in which one of the anilino hydrogens is replaced by a 3,4-dimethoxycinnamoyl group. Among its listed roles, it functions as a anti-asthmatic drug, a nephroprotective agent, an anti-allergic agent, a calcium channel blocker, an antineoplastic agent, an aryl hydrocarbon receptor agonist and a hepatoprotective agent. It belongs to the class of cinnamamides, a dimethoxybenzene, an amidobenzoic acid and a secondary carboxamide. Functionally, it is related to anthranilic acid. Its therapeutic use is listed as adhesion-prevention agents and anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rizaben, Tranilastum and Tranpro. Its PubChem CID is 5282230.
Tranilast
| CAS No | 53902-12-8 |
|---|---|
| Molecular Formula | C18H17NO5 |
| Molecular Weight | 327.3 g/mol |
| Synonyms | 2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tranilast is an amidobenzoic acid that is anthranilic acid in which one of the anilino hydrogens is replaced by a 3,4-dimethoxycinnamoyl group.
The listed CAS number is 53902-12-8.
The listed molecular formula is C18H17NO5.
The listed molecular weight is 327.3 g/mol.
2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid.
The source lists Rizaben, Tranilastum and Tranpro.